[1] Glisson JK,Walker LA.How physicians should evaluate dietary supplements[J].The American Journal of Medicine,2010,123(7):577-582. [2] Sun Y,Xiao HL.Thoughts on EMA herbal quality standards guide(draft revision 3)[J].Drug Evaluation Research(药物评价研究),2019,16(12):750-756. [3] Singh A,Zhao K.Herb-drug interactions of commonly used Chinese medicinal herbs[J].Int Rev Neurobiol,2017,135:197-232. [4] Parvez MK,Rishi V.Herb-drug interactions and hepatotoxicity[J].Curr Drug Metab,2019,20(4):275-282. [5] Choi YH,Chin YW,Kim YG.Herb-drug interactions:focus on metabolic enzymes and transporters[J].Arch Pharm Res,2011,34(11):1843-1863. [6] Li H,Zhang GP,Yang YF,et al.Study on toxicity reduction mechanism of aconitine combined with ginsenoside and liquiritin based on drug metabolic enzyme CYP3A4[J].Chinese Traditional and Herbal Drugs(中草药),2020,43(2):199-205. [7] Wienkers LC,Heath TG.Predicting in vivo drug interactions from in vitro drug discovery data[J].Nat Rev Drug Discov,2005,4(10):825-833. [8] Fritz A,Busch D,Lapczuk J,et al.Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors:An intra-subject analysis[J].Basic Clin Pharmacol Toxicol,2019,124(3):245-255. [9] Fasinu PS,Bouic PJ,Rosenkranz B.An overview of the evidence and mechanisms of herb-drug interactions[J].Front Pharmacol,2012,3:69. [10] Nayeri A,Wu S,Adams E,et al.Acute calcineurin inhibitor nephrotoxicity secondary to turmeric intake:a case report[J].Transplant Proc,2017,49(1):198-200. [11] Ma S,Dai G,Bi X,et al.The herb-drug interaction of clopidogrel and Xuesaitong dispersible tablet by modulation of the pharmacodynamics and liver carboxylesterase 1A metabolism[J].Evidence-Based Complementary and Alternative Medicine,2018,2018(3):1-8. [12] Luan XW.Drug interaction mechanism and risk prediction of combination ginseng with irinotecan[D].Dalian University of Technology,2019. [13] El-Kattan AF,Varma MVS.Navigating transporter sciences in pharmacokinetics characterization using the extended clearance classification system[J].Drug Metabolism and Disposition,2018,46(5):729-739. [14] DeGorter MK,Xia CQ,Yang JJ,et al.Drug transporters in drug efficacy and toxicity[J].Annual Review of Pharmacology and Toxicology,2012,52(1):249-273. [15] Rees DC,Johnson E,Lewinson O.ABC transporters:the power to change[J].Nat Rev Mol Cell Biol,2009,10(3):218-227. [16] Wu X,Ma J,Ye Y,et al.Transporter modulation by Chinese herbal medicines and its mediated pharmacokinetic herb-drug interactions[J].Journal of Chromatography B,2016,1026:236-253. [17] Liu W,Liu G,Liu J.Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats[J].Xenobiotica,2019,49(10):1173-1177. [18] Pingili RB,Pawar AK,Challa SR.Systemic exposure of Paracetamol(acetaminophen) was enhanced by quercetin and chrysin co-administration in Wistar rats andin vitromodel:risk of liver toxicity[J].Drug Development and Industrial Pharmacy,2015,41(11):1793-1800. [19] Wlcek K,Stieger B.ATP-binding cassette transporters in liver[J].Bio Factors,2014,40(2):188-198. [20] Riley RJ,Foley SA,Barton P,et al.Hepatic drug transporters:the journey so far[J].Expert Opinion on Drug Metabolism &Toxicology,2016,12(2):201-216. [21] Telbisz Á,Homolya L.Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function[J].Expert Opinionon Therapeutic Targets,2015,20(4):501-514. [22] Chi YC,Juang SH,Chui WK,et al.Acute and chronic administrations of rheum palmatum reduced the bioavailability of phenytoin in rats:a new herb-drug interaction[J].Evidence-Based Complementary and Alternative Medicine,2013,2013:1-9. [23] Qu XY,Zhang YM,Zhang SX,et al.Dysregulation of BSEP and MRP2 may play an important role in isoniazid-induced liver injury via the SIRT1/FXR pathway in rats and HepG2 cells[J].Biological &Pharmaceutical Bulletin,2018,41(8):1211-1218. [24] Qu XY,Tao LN,Zhang SX,et al.The role of Ntcp,Oatp2,Bsep and Mrp2 in liver injury induced by Dioscorea bulbifera L.and Diosbulbin B in mice[J].Environ Toxicol Pharmacol,2017,51(16):16-22. [25] Morris ME,Rodriguez-Cruz V,Felmlee MA.SLC and ABC transporters:expression,localization,and species differences at the blood-brain and the blood-cerebrospinal fluid barriers[J].Aaps Journal,2017,19:1317-1331. [26] Staud F,Ceckova M.Regulation of drug transporter expression and function in the placenta[J].Expert Opin Drug Metab Toxicol,2015,11(4):1-23. [27] Kurrimbux D,Gaffen Z,Farrell CL,et al.The involvement of the blood-brain and the blood-cerebrospinal fluid barriers in the distribution of leptin into and out of the rat brain[J].Neuroscience,2004,123(2):527-536. [28] Chi YC,Lin SP,Hou YC.A new herb-drug interaction of Polygonum cuspidatum,a resveratrol-rich nutraceutical,with carbamazepine in rats[J].Toxicol Appl Pharmacol,2012,263(3):315-322. [29] Chang TKH.Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines[J].The AAPS Journal,2009,11(3):590-601. [30] Sachar M,Ma X.Nuclear receptors in herb-drug interactions[J].Drug Metab Rev,2013,45(1):73-78. [31] Hogle BC,Guan X,Folan MM,et al.PXR as a mediator of herb-drug interaction[J].Journal of Food and Drug Analysis,2018,26(2):S26-S31. [32] Müller J,Keiser M,Drozdzik M,et al.Expression,regulation and function of intestinal drug transporters:an update[J].Biological Chemistry,2017,398(2):175-192. [33] Kittayaruksakul S,Sawasvirojwong S,Noitem R,et al.Activation of constitutive androstane receptor inhibits intestinal CFTR-mediated chloride transport[J].Biomedicine &Pharmacotherapy,2019,111:1249-1259. [34] Huang L,Bi HC,Liu YH,et al.CAR-mediated up-regulation of CYP3A4 expression in LS174T cells by Chinese herbal compounds[J].Drug Metabolism and Pharmacokinetics,2011,26(4):331-340. [35] Irfan M,Kwak YS,Han CK,et al.Adaptogenic effects of Panax ginseng on modulation of cardiovascular functions[J].Journal of Ginseng Research,2020,44(4):538-543. [36] Dong H,Ma J,Li T,et al.Global deregulation of ginseng products may be a safety hazard to warfarin takers:solid evidence of ginseng-warfarin interaction[J].Scientific Reports,2017,7(1):5813. [37] Xue X,Quan Y,Gong L,et al.A review of the processed Polygonum multiflorum (Thunb.) for hepatoprotection:clinical use,pharmacology and toxicology[J].J Ethnopharmacol,2020,261:113-121. [38] Li HY,Yang CP,Jin HT.Recent research progress in mechanism of liver injury induced by common drugs[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2019,16(12):750-756. [39] Xu S,Liu J,Shi J,et al.2,3,4′,5-tetrahydroxystilbene-2-O-β-D-glucoside exacerbates acetaminophen-induced hepatotoxicity by inducing hepatic expression of CYP2E1,CYP3A4 and CYP1A2[J].Scientific Reports,2017,7(1):16511. [40] Chrubasik-Hausmann S,Vlachojannis J,McLachlan AJ.Understanding drug interactions with St John's wort (Hypericum perforatum L.):impact of hyperforin content[J].J Pharm Pharmacol,2019,71(1):129-138. [41] Barnes J,Arnason JT,Roufogalis BD.St John's wort (Hypericum perforatum L.):botanical,chemical,pharmacological and clinical advances[J].J Pharm Pharmacol,2019,71(1):1-3. [42] Tian R,Koyabu N,Morimoto S,et al.Functional induction and de-induction of P-glycoprotein by St.John's wort and its ingredients in a human colon adenocarcinoma cell line[J].Drug Metabolism and Disposition,2005,33(4):547-554. [43] Gurley BJ,Swain A,Williams DK,et al.Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions:Comparative effects of St.John's wort,Echinacea,clarithromycin,and rifampin on digoxin pharmacokinetics[J].Molecular Nutrition &Food Research,2008,52(7):772-779. [44] Andrén L,Andreasson Å,Eggertsen R.Interaction between a commercially available St.John’s wort product (Movina) and atorvastatin in patients with hypercholesterolemia[J].European Journal of Clinical Pharmacology,2007,63(10):913-916. [45] Markowitz SJ.Effect of St John’s wort on drug metabolism by induction of cytochrome P450 3A4 enzyme[J].Jama the Journal of the American Medical Association,2003,290(11):1500. [46] Cheng FR,Cui HX,Fang JL,et al.Ameliorative effect and mechanism of the purified anthraquinone-glycoside preparation from rheum palmatum L.on type 2 diabetes mellitus[J].Molecules,2019,24(8):1454. [47] Dodd-Butera T,Broderick M.Cyclosporine[J].Encyclopedia of Toxicology,2014,322:1114-1117. [48] Yu CP,Lin HJ,Lin SP,et al.Rhubarb decreased the systemic exposure of cyclosporine,a probe substrate of P-glycoprotein and CYP 3A[J].Xenobiotica,2015,46(8):677-682. [49] Wang L,Pan X,Sweet DH.The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination[J].Biochemical Pharmacology,2013,86(7):991-996. [50] Wang SJ,Xu Z,Cai B,et al.Berberine as potential multi-target agent for metabolic diseases:a review of investigations for berberine[J].Endocrine,Metabolic &Immune Disorders Drug Targets,2020,20:1-11. [51] Zou K,Li Z,Zhang Y,et al.Advances in the study of berberine and its derivatives:A focus on anti-inflammatory and anti-tumor effects in the digestive system[J].Acta Pharmacologica Sinica,2016,38(2):157-167. [52] Singh A,Zhao K,Bell C,et al.Effect of berberine on in vitro metabolism of sulfonylureas:a herb-drug interactions study[J].Rapid Communications in Mass Spectrometry,2019,34(S4):e8651 [53] Gökalp O,Gunes A,Çam H,et al.Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9,CYP2C19 and CYP2C8 polymorphisms in routine clinical setting[J].European Journal of Clinical Pharmacology,2011,67(12):1223-1229. |